EN
0
Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > ((3S,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethyl sulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate) calcium(II)
((3S,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethyl sulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate) calcium(II) structure, CAS 2185805-14-3

((3S,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethyl sulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate) calcium(II)

CAS Number2185805-14-3

SynonymsRosuvastatin calcium (3S, 5S) isomer; Rosuvastatin calcium (3S, 5S) isomer (rosuvastatin impurity 60); Rosuvastatin calcium impurity B01

Molecular FormulaC44H54O12N6S2F2Ca1

Molecular Weight1001.15

Purity

Density

Boiling Point

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-3181989 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Inquiry

Quality Control of [ 2185805-14-3 ] SDS Specification MoL

COA NMR CNMR HPLC LC-MS
Chemical & Physical Properties
CAS Number2185805-14-3
Catalog No.2A-3181989
Chinese Name瑞舒伐他汀钙杂质B01
SynonymsRosuvastatin calcium (3S, 5S) isomer; Rosuvastatin calcium (3S, 5S) isomer (rosuvastatin impurity 60); Rosuvastatin calcium impurity B01
Molecular FormulaC44H54O12N6S2F2Ca1
Molecular Weight1001.15
PubChem ID126630200
MDL NumberMFCD00953841
SMILESCC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1C=CC(O)CC(O)CC(=O)O.[Ca]
InChIInChI=1S/2C22H28FN3O6S.Ca/c2*1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32;/h2*5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30);/q;;+2/p-2/b2*10-9+;/t2*16-,17+;/m11./s1
InChI KeyAVDMILNVMOXCHF-ZPYSVEHQSA-N
Related Products in Pharmaceutical Intermediates
4-amino-1-[(2S,4S,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,hydrochloride122111-05-12A-3181905
6,8-Difluoro-1,4-dihydro-1-(MethylaMino)-7-(4-Methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid Sulfate100276-37-72A-3181980
N-[(6S)-8-Fluoro-5,6-dihydro-4-(1-Methylethyl)-6-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]benzo[h]quinazolin-2-yl]-N-MethylMethanesulfonaMide854898-47-82A-3181984
(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid1714147-47-32A-3181986
((3S,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethyl sulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate)calcium (II)1422515-55-62A-3181988
(3R,5S,Z)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept- 6-enoic acid calcium(II)1444772-08-02A-3181990
(3R,5S)-5-((S)-8-fluoro-4-isopropyl-2-(N-methylmethyl sulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl)-3,5- dihydroxypentanoate calcium(II)854898-50-32A-3181991
(3R,5S)-5-((R)-8-fluoro-4-isopropyl-2-(N-methylmethylsulfonam ido)-5,6-dihydrobenzo[h]quinazolin-6-yl)-3,5-dihydroxypentanoate calcium(II)854898-49-02A-3181992
(1R,2R,3S,5R)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol2096989-55-62A-3181997
(1S,2S,3R,5S)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol2096989-56-72A-3181998
Browse all Pharmaceutical Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA